Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat

被引:115
作者
Piteau, Shalea
Olver, Amy
Kim, Su-Jin
Winter, Kyle
Pospisilik, John Andrew
Lynn, Francis
Manhart, Susanne
Demuth, Hans-Ulrich
Speck, Madeleine
Pederson, Raymond A.
McIntosh, Christopher H. S.
机构
[1] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
[2] Inst Mol Biotechnol, Vienna, Austria
[3] Univ Calif San Francisco, Ctr Diabet, HRI, San Francisco, CA 94143 USA
[4] Probiodrug AG, Bioctr, Halle, Germany
基金
加拿大健康研究院; 加拿大创新基金会;
关键词
gastric inhibitory polypeptide; glucose-dependent insulinotropic polypeptide; receptor down-regulation; hyperglycemia; phlorizin; dipeptidyl peptidase IV;
D O I
10.1016/j.bbrc.2007.08.115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In type 2 diabetes (T2DM) beta-cell responsiveness to glucose-dependent insulinotropic polypeptide (GIP) is reduced. In a model of T2DM, the VDF Zucker rat, GIP receptor mRNA and protein levels were shown to be down-regulated. Possible restoration of responsiveness to GIP in Zucker rats by reducing hyperglycemia has been examined. ZDF rats with extreme hyperglycemia demonstrated greater islet GIP receptor mRNA down-regulation (94.3 +/- 3.8%) than ZF rats (48.8 +/- 22.8%). GIP receptor mRNA levels in ZDF rats returned to 83.0 +/- 17.9% of lean following normalization of hyperglycemia by phlorizin treatment and pancreas perfusions demonstrated markedly improved GIP responsiveness. Treatment of VDF rats with a DP IV inhibitor (P32/98) resulted in improved glucose tolerance and restored sensitivity to GIP in isolated pancreata. These findings support the proposal that GIP receptor down-regulation in rodent T2DM is secondary to chronic hyperglycemia and that normalization of glycemia can restore GIP sensitivity. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1007 / 1012
页数:6
相关论文
共 32 条
[1]   Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells [J].
Almind, K ;
Ambye, L ;
Urhammer, SA ;
Hansen, T ;
Echwald, SM ;
Holst, JJ ;
Gromada, J ;
Thorens, B ;
Pedersen, O .
DIABETOLOGIA, 1998, 41 (10) :1194-1198
[2]  
Demuth H U, 1990, J Enzyme Inhib, V3, P249, DOI 10.3109/14756369009030375
[3]   The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].
Drucker, Daniel J. ;
Nauck, Michael A. .
LANCET, 2006, 368 (9548) :1696-1705
[4]   The biology of incretin hormones [J].
Drucker, DJ .
CELL METABOLISM, 2006, 3 (03) :153-165
[5]   Phlorizin: a review [J].
Ehrenkranz, JRL ;
Lewis, NG ;
Kahn, CR ;
Roth, J .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (01) :31-38
[6]   Glucose-dependent insulinotropic polypeptide promotes β-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase [J].
Ehses, JA ;
Casilla, VR ;
Doty, T ;
Pospisilik, JA ;
Winter, KD ;
Demuth, HU ;
Pederson, RA ;
McIntosh, CHS .
ENDOCRINOLOGY, 2003, 144 (10) :4433-4445
[7]   THE INSULINOTROPIC ACTIONS OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) AND GLUCAGON-LIKE PEPTIDE-1(7-37) IN NORMAL AND DIABETIC SUBJECTS [J].
ELAHI, D ;
MCALOONDYKE, M ;
FUKAGAWA, NK ;
MENEILLY, GS ;
SCLATER, AL ;
MINAKER, KL ;
HABENER, JF ;
ANDERSEN, DK .
REGULATORY PEPTIDES, 1994, 51 (01) :63-74
[8]   INSULINOTROPIC HORMONE GLUCAGON-LIKE PEPTIDE-I(7-37) STIMULATION OF PROINSULIN GENE-EXPRESSION AND PROINSULIN BIOSYNTHESIS IN INSULINOMA BETA-TC-1 CELLS [J].
FEHMANN, HC ;
HABENER, JF .
ENDOCRINOLOGY, 1992, 130 (01) :159-166
[9]   CHARACTERIZATION OF GIP(1-30) AND GTP(1-42) AS STIMULATORS OF PROINSULIN GENE-TRANSCRIPTION [J].
FEHMANN, HC ;
GOKE, B .
PEPTIDES, 1995, 16 (06) :1149-1152
[10]   Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats [J].
Harmon, JS ;
Gleason, CE ;
Tanaka, Y ;
Poitout, V ;
Robertson, RP .
DIABETES, 2001, 50 (11) :2481-2486